The ROE as of June 2026 (TTM) for Neoleukin Therapeutics, Inc. (NLTX) is -37.88%

According to Neoleukin Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -37.88%. This represents a change of 295.71% compared to the average of -9.57% of the last 4 quarters.

Neoleukin Therapeutics, Inc. (NLTX) Historical ROE (quarterly & annually)

How has NLTX ROE performed in the past?

The mean historical ROE of Neoleukin Therapeutics, Inc. over the last ten years is -36.82%. The current -37.88% ROE has changed 2.90% with respect to the historical average. Over the past ten years (40 quarters), NLTX's ROE was at its highest in in the June 2018 quarter at 3.22%. The ROE was at its lowest in in the September 2019 quarter at -88.42%.

Neoleukin Therapeutics, Inc. (NLTX) ROE by Quarter and Year

Discovering the peaks and valleys of Neoleukin Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Neoleukin Therapeutics, Inc. (NLTX) Average ROE

How has NLTX ROE performed in the past?

The current ROE of Neoleukin Therapeutics, Inc. (NLTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Neoleukin Therapeutics, Inc. (NLTX) ROE vs. Peers

How is NLTX’s ROE compared to its peers?

Neoleukin Therapeutics, Inc.’s ROE is less than Lannett Company, Inc. (166.31%), greater than DMK Pharmaceuticals Corporation (-209.88%), less than Biora Therapeutics, Inc. (121.86%), less than ProSomnus, Inc. (102.32%), greater than Turnstone Biologics Corp. (-136.68%), greater than Tvardi Therapeutics, Inc. (-64.17%), greater than COSCIENS Biopharma Inc. (-13.16%), greater than Omega Therapeutics, Inc. (-118.82%), greater than Channel Therapeutics Corporation (-164.11%), less than Centogene N.V. (397.65%),

Build a custom stock screener for Neoleukin Therapeutics, Inc. (NLTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neoleukin Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Neoleukin Therapeutics, Inc. (NLTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Neoleukin Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.